Radiographic resolution of chronic rhinosinusitis without polyposis after 6 weeks vs 3 weeks of oral antibiotics

Ann Allergy Asthma Immunol. 2007 Jan;98(1):32-5. doi: 10.1016/S1081-1206(10)60856-3.

Abstract

Background: Maximal medical therapy is poorly defined in chronic sinusitis treatment.

Objective: To objectively evaluate the radiographic response of chronic rhinosinusitis without polyposis after 3 and 6 weeks of oral antibiotics.

Methods: Thirty-five patients with confirmed chronic sinusitis without polyposis (disease apparent on initial computed tomography [CT] with appropriate symptom duration) were prescribed 6 weeks of antibiotics. When possible, culture-directed antibiotics were used; otherwise clindamycin was used empirically. A CT was performed after 3 and 6 weeks of therapy. CTs were then graded by the Lund-Mackay system. Demographic data were reviewed.

Results: Of the 35 patients, 16 underwent all 3 CT scans and completed all 6 weeks of antibiotics. Three patients completed only 3 weeks of antibiotics, and 16 did not undergo the interval 3-week CT. Six patients (38%) had statistically significant improvement in their CT scans between weeks 3 and 6. In this subset of patients who improved, 37% of their overall radiographic improvement occurred in the 3- to 6-week treatment interval. No prognostic variables predicted which patients would radiographically improve after 3 weeks of antibiotics.

Conclusion: Some patients achieve radiographic improvement and disease resolution after the completion of a 3-week course of antibiotics. Therefore, maximal medical therapy for chronic sinusitis may consist of longer than 3 weeks of therapy to ensure maximal benefit.

MeSH terms

  • Administration, Oral
  • Anti-Bacterial Agents / administration & dosage*
  • Chronic Disease
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nasal Polyps
  • Retrospective Studies
  • Rhinitis / diagnostic imaging*
  • Rhinitis / drug therapy*
  • Sinusitis / diagnostic imaging*
  • Sinusitis / drug therapy*
  • Time Factors
  • Tomography, X-Ray Computed

Substances

  • Anti-Bacterial Agents